Schroder Investment Management Group
GBT

Schroder Investment Management Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Schroder Investment Management Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-249,107
Closed -$17M – 1349
2022
Q3 		$17M Buy
249,107
+6,965
+3% +$384K 0.03% 488
2022
Q2 		$7.74M Sell
242,142
-25,340
-9% -$742K 0.01% 703
2022
Q1 		$9.35M Buy
267,482
+106,136
+66% +$3.17M 0.01% 680
2021
Q4 		$4.72M Buy
161,346
+58,208
+56% +$1.8M 0.01% 772
2021
Q3 		$2.63M Buy
103,138
+17,833
+21% +$524K ﹤0.01% 917
2021
Q2 		$2.99M Buy
85,305
+35,040
+70% +$1.37M ﹤0.01% 940
2021
Q1 		$2.05M Buy
50,265
+8,069
+19% +$371K ﹤0.01% 1014
2020
Q4 		$1.83M Sell
42,196
-40,225
-49% -$1.98M ﹤0.01% 1021
2020
Q3 		$4.7M Buy
82,421
+28,619
+53% +$1.82M 0.01% 734
2020
Q2 		$3.4M Buy
53,802
+20,360
+61% +$1.4M 0.01% 733
2020
Q1 		$1.92M Buy
33,442
+2,115
+7% +$142K ﹤0.01% 802
2019
Q4 		$2.49M Hold
31,327
– – ﹤0.01% 852
2019
Q3 		$1.54M Buy
31,327
+1,360
+5% +$70.9K ﹤0.01% 928
2019
Q2 		$1.58M Buy
29,967
+2,482
+9% +$143K ﹤0.01% 854
2019
Q1 		$1.46M Buy
+27,485
New +$1.35M ﹤0.01% 848

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Schroder Investment Management Group's GBT Position: Q4 2022 in Review

Schroder Investment Management Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 249,107 shares — an estimated $17M sold.

Schroder Investment Management Group first reported a position in GBT in Q1 2019 and held it in 15 quarters. The position peaked at $17M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Schroder Investment Management Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 249,107 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $17M.
  • Schroder Investment Management Group first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 15 quarters.
  • Schroder Investment Management Group's Global Blood Therapeutics, Inc. position peaked at $17M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Schroder Investment Management Group's 13F filing for Q4 2022, filed 10 Feb 2023.